Evaluation of the Occurrence of Acute Complications Caused by a Central Venous Catheter Placement

Centre Leon Berard1,780 enrolled

Overview

It is an observational, prospective, monocentric study. The purpose of the study is to assess the acute complications rate caused by a central venous catheter placement. All the patients who require a central venous placement could be enrolled in the study. The study will not change the usual practice. The placement will be on day 1 and patients will be contacted by phone on day 7 to identify potential complications and to assess pain. Anaesthesia staff will keep patients under surveillance to control the absence of late complications.

Study Type

OBSERVATIONAL

Enrollment

1,780

Conditions

Anesthesia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \>= 18. * Patient who requires the placement of a central venous catheter (a portacath (PAC), a peripherally inserted central catheter (PICC) or a tunnelled catheter). * Patient able to understand, read and write French. * Mandatory affiliation with a health insurance system. Exclusion Criteria: * Active infection at placement of the central venous catheter. * Patient who can't be contacted by phone. * Patient who is likely to have a femoral venous catheter placement.

Locations (1)

Centre Léon Bérard

Lyon, France

Outcomes

Primary Outcomes

Estimate the acute complications rate

Placement of the central venous catheter on day 1 and follow-up of potential acute complications

Time frame: From day 1 to day 7

Secondary Outcomes

Assess the preoperative anxiety

By means of Beck anxiety inventory

Time frame: On day 1

Assess patients satisfaction about the catheter

By means of a questionnary filled in by patients at home

Time frame: On day 7

Assess postoperative pain

The pain will be assessed on day 1 by a visual analogic scale and on day 7 by a verbal numeric scale

Time frame: On day 1 and on day 7

Assess the rate of late complications

The anaesthesia staff will keep patients under surveillance for potential late complications.

Time frame: Up to 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.